These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 21292076)

  • 1. Prenatal diagnosis and outcome of fetal lung masses.
    Cass DL; Olutoye OO; Cassady CI; Moise KJ; Johnson A; Papanna R; Lazar DA; Ayres NA; Belleza-Bascon B
    J Pediatr Surg; 2011 Feb; 46(2):292-8. PubMed ID: 21292076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic adenomatoid malformation volume ratio predicts outcome in prenatally diagnosed cystic adenomatoid malformation of the lung.
    Crombleholme TM; Coleman B; Hedrick H; Liechty K; Howell L; Flake AW; Johnson M; Adzick NS
    J Pediatr Surg; 2002 Mar; 37(3):331-8. PubMed ID: 11877643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining hydrops and indications for open fetal surgery for fetuses with lung masses and vascular tumors.
    Cass DL; Olutoye OO; Ayres NA; Moise KJ; Altman CA; Johnson A; Cassady CI; Lazar DA; Lee TC; Lantin MR
    J Pediatr Surg; 2012 Jan; 47(1):40-5. PubMed ID: 22244390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal lung lesions: management and outcome.
    Adzick NS; Harrison MR; Crombleholme TM; Flake AW; Howell LJ
    Am J Obstet Gynecol; 1998 Oct; 179(4):884-9. PubMed ID: 9790364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective study of prenatal diagnosed pulmonary sequestration.
    Zhang H; Tian J; Chen Z; Ma X; Yu G; Zhang J; Jiang G; Wang L
    Pediatr Surg Int; 2014 Jan; 30(1):47-53. PubMed ID: 24258515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of Fetal Magnetic Resonance Imaging in Prognosis Assessment of Fetuses With Congenital Pulmonary Cystic Diseases].
    Jia Y; Bao L; Xu R; Xie L; Ye L; Guo Y; Chen H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May; 55(3):717-723. PubMed ID: 38948284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current outcome of antenally diagnosed cystic lung disease.
    Davenport M; Warne SA; Cacciaguerra S; Patel S; Greenough A; Nicolaides K
    J Pediatr Surg; 2004 Apr; 39(4):549-56. PubMed ID: 15065026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal steroids for microcystic congenital cystic adenomatoid malformations.
    Curran PF; Jelin EB; Rand L; Hirose S; Feldstein VA; Goldstein RB; Lee H
    J Pediatr Surg; 2010 Jan; 45(1):145-50. PubMed ID: 20105595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large fetal congenital cystic adenomatoid malformations: growth trends and patient survival.
    Kunisaki SM; Barnewolt CE; Estroff JA; Ward VL; Nemes LP; Fauza DO; Jennings RW
    J Pediatr Surg; 2007 Feb; 42(2):404-10. PubMed ID: 17270558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of congenital lung lesions.
    Adzick NS; Flake AW; Crombleholme TM
    Semin Pediatr Surg; 2003 Feb; 12(1):10-6. PubMed ID: 12520469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of pediatric outcome after prenatal diagnosis and expectant antenatal management of congenital cystic adenomatoid malformation.
    Yong PJ; Von Dadelszen P; Carpara D; Lim K; Kent N; Tessier F; Delisle MF; Wong T; Blair G; Skarsgard ED
    Fetal Diagn Ther; 2012; 31(2):94-102. PubMed ID: 22310905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal intervention for congenital cystic adenomatoid malformation.
    Harrison MR; Adzick NS; Jennings RW; Duncan BW; Rosen MA; Filly RA; Goldberg JD; deLorimier AA; Golbus MS
    Lancet; 1990 Oct; 336(8721):965-7. PubMed ID: 1977005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Neurodevelopmental and Respiratory Outcome after Intrauterine Therapy for Fetal Thoracic Abnormalities.
    Witlox RSGM; Lopriore E; Rijken M; Klumper FJCM; Oepkes D; van Klink JMM
    Fetal Diagn Ther; 2019; 45(3):162-167. PubMed ID: 29734144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial lung mass volume ratios as prognostic indicators of neonatal respiratory morbidity in fetal pulmonary malformations.
    Penikis AB; Zhou AL; Sferra SR; Engwall-Gill AJ; Miller JL; Baschat AA; Blakemore KJ; Kunisaki SM
    Am J Obstet Gynecol MFM; 2023 Oct; 5(10):101128. PubMed ID: 37572880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of congenital cystic adenomatoid malformations associated with nonimmune hydrops and outcome.
    Vu L; Tsao K; Lee H; Nobuhara K; Farmer D; Harrison M; Goldstein RB
    J Pediatr Surg; 2007 Aug; 42(8):1351-6. PubMed ID: 17706495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal thoracoamniotic shunting for large macrocystic congenital cystic adenomatoid malformations of the lung.
    Schrey S; Kelly EN; Langer JC; Davies GA; Windrim R; Seaward PG; Ryan G
    Ultrasound Obstet Gynecol; 2012 May; 39(5):515-20. PubMed ID: 22223532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors associated with congenital cystic adenomatoid malformation of the lung.
    Bunduki V; Ruano R; da Silva MM; Miguelez J; Miyadahira S; Maksoud JG; Zugaib M
    Prenat Diagn; 2000 Jun; 20(6):459-64. PubMed ID: 10861709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal lung lesions: can we start to breathe easier?
    Ehrenberg-Buchner S; Stapf AM; Berman DR; Drongowski RA; Mychaliska GB; Treadwell MC; Kunisaki SM
    Am J Obstet Gynecol; 2013 Feb; 208(2):151.e1-7. PubMed ID: 23159697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ex utero intrapartum therapy procedure for high-risk fetal lung lesions.
    Hedrick HL; Flake AW; Crombleholme TM; Howell LJ; Johnson MP; Wilson RD; Adzick NS
    J Pediatr Surg; 2005 Jun; 40(6):1038-43; discussion 1044. PubMed ID: 15991193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal lung masses: prenatal course and outcome.
    Bromley B; Parad R; Estroff JA; Benacerraf BR
    J Ultrasound Med; 1995 Dec; 14(12):927-36; quiz p1378. PubMed ID: 8583529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.